In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Molecule AI is revolutionising drug discovery by using artificial intelligence to predict molecular combinations and ...
A Senate hearing probed whether the Food and Drug Administration's process for approving rare-disease therapies is ...
Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...
2don MSN
Smart materials and drug delivery could exploit lipid molecules that reorganize at drying interfaces
Minor changes in moisture level can promote lipid molecules to reorganize themselves in biomaterial or biomembranes. This can affect how the skin, lungs and tear film protect us from dehydration. This ...
Rare genetic diseases such as ataxia telangiectasia and cystic fibrosis lack strong commercial incentives, prompting ...
In an effort to battle against what members feel is an existential threat to their business, a group of 10 domestic biotech companies have launched the Midsized Biotech Alliance of America with a ...
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations.
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results